Castleview Partners, LLC Adicet Bio, Inc. Transaction History
Castleview Partners, LLC
- $151 Million
- Q4 2024
A detailed history of Castleview Partners, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Castleview Partners, LLC holds 47,903 shares of ACET stock, worth $43,112. This represents 0.03% of its overall portfolio holdings.
Number of Shares
47,903
Previous 52,368
8.53%
Holding current value
$43,112
Previous $50,000
10.0%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59.2MCall Options Held
4.2KPut Options Held
6.7K-
Orbimed Advisors LLC San Diego, CA11.4MShares$10.3 Million0.39% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$7.4 Million1.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$6.79 Million0.15% of portfolio
-
Goldman Sachs Group Inc New York, NY3.76MShares$3.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.89 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $36M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...